The toxic side effects of an experimental cancer drug from Onyx Pharmaceuticals may outweigh its benefits for patients with a type of blood cancer, federal health regulators said Monday.
Facebook to buy facial-recognition startup
June 18th, 2012 FAKE NEWS for the Zionist agenda